C4 Therapeutics, Inc. - CCCC - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	19	21	33	46	31	21	36	36	28	📊
Revenue Growth (1Y)	--	+10.42%	+55.25%	+37.93%	-32.08%	-33.25%	+71.44%	+1.02%	-21.00%	📊
Revenue Growth (5Y)	--	--	--	--	+60.59%	-2.92%	+7.20%	-21.49%	-37.98%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	29	48	77	3	8	8	8	8	2	📊
Cost of Revenue Growth (1Y)	--	+66.70%	+62.53%	-96.25%	+160.47%	+2.18%	+2.03%	+1.03%	-77.42%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-73.52%	-83.77%	-89.81%	+174.34%	-38.05%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	-9	-26	-44	43	24	13	36	28	27	📊
Gross Profit Growth (1Y)	--	-184.82%	-68.45%	+196.85%	-45.14%	-44.66%	+173.32%	-21.39%	-4.92%	📊
Gross Profit Growth (5Y)	--	--	--	--	+354.92%	+149.53%	+180.37%	-34.76%	-37.97%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	36	57	94	125	153	152	155	132	145	📊
Operating Expenses Growth (1Y)	--	+58.96%	+64.77%	+33.50%	+22.43%	-0.66%	+2.07%	-14.65%	+9.47%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+328.10%	+167.54%	+65.73%	+5.96%	+15.99%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	7	9	15	33	43	42	42	36	34	📊
Research and Development	29	48	78	95	118	118	111	104	100	📊
Other Income Expenses	-0	0	0	-3	-8	-8	2	-8	11	📊
EBITDA	-15	-31	-63	-79	-124	-122	-103	-103	-107	📊
EBITDA Growth (1Y)	--	-102.14%	-105.82%	-25.36%	-57.64%	+1.75%	+15.34%	+0.44%	-3.81%	📊
EBITDA Growth (5Y)	--	--	--	--	-722.20%	-299.60%	-64.36%	-30.54%	-35.50%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	4	3	3	3	2	8	2	2	3	📊
Operating Income	-16	-35	-60	-82	-130	-139	-120	-104	-112	📊
Operating Income Growth (1Y)	--	-116.32%	-70.51%	-35.87%	-57.71%	-7.33%	+13.97%	+12.64%	-6.96%	📊
Operating Income Growth (5Y)	--	--	--	--	-690.37%	-292.17%	-97.88%	-27.22%	-36.08%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	1	2	2	1	0	0	--	📊
Pre Tax Income	-16	-33	-67	-84	-128	-131	-105	-105	-101	📊
Tax Provision	0	1	-1	2	-2	1	0	0	--	📊
NET INCOME	-16	-34	-66	-84	-128	-132	-105	-105	-101	📊
Net Income Growth (1Y)	--	-117.04%	-94.54%	-26.47%	-52.79%	-3.37%	+20.51%	+0.31%	+3.41%	📊
Net Income Growth (5Y)	--	--	--	--	-715.83%	-288.55%	-58.76%	-25.15%	-20.89%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.06	-0.79	-1.54	-1.82	-2.62	-2.67	-1.52	-1.27	-1	📊
Diluted EPS	-1.06	-0.79	-1.54	-1.82	-2.62	-2.67	-1.52	-1.27	-1	📊
Basic Average Shares	15	43	43	46	49	50	69	83	112	📊
Diluted Average Shares	42	43	43	46	49	50	69	83	112	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+10.42%

+55.25%

+37.93%

-32.08%

-33.25%

+71.44%

+1.02%

-21.00%

📊

Revenue Growth (5Y)

+60.59%

-2.92%

+7.20%

-21.49%

-37.98%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+66.70%

+62.53%

-96.25%

+160.47%

+2.18%

+2.03%

+1.03%

-77.42%

📊

Cost of Revenue Growth (5Y)

-73.52%

-83.77%

-89.81%

+174.34%

-38.05%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-9

-26

-44

📊

Gross Profit Growth (1Y)

-184.82%

-68.45%

+196.85%

-45.14%

-44.66%

+173.32%

-21.39%

-4.92%

📊

Gross Profit Growth (5Y)

+354.92%

+149.53%

+180.37%

-34.76%

-37.97%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

125

153

152

155

132

145

📊

Operating Expenses Growth (1Y)

+58.96%

+64.77%

+33.50%

+22.43%

-0.66%

+2.07%

-14.65%

+9.47%

📊

Operating Expenses Growth (5Y)

+328.10%

+167.54%

+65.73%

+5.96%

+15.99%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

118

111

104

100

📊

Other Income Expenses

-0

-3

-8

📊

EBITDA

-15

-31

-63

-79

-124

-122

-103

-107

📊

EBITDA Growth (1Y)

-102.14%

-105.82%

-25.36%

-57.64%

+1.75%

+15.34%

+0.44%

-3.81%

📊

EBITDA Growth (5Y)

-722.20%

-299.60%

-64.36%

-30.54%

-35.50%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-16

-35

-60

-82

-130

-139

-120

-104

-112

📊

Operating Income Growth (1Y)

-116.32%

-70.51%

-35.87%

-57.71%

-7.33%

+13.97%

+12.64%

-6.96%

📊

Operating Income Growth (5Y)

-690.37%

-292.17%

-97.88%

-27.22%

-36.08%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-16

-33

-67

-84

-128

-131

-105

-101

📊

Tax Provision

-1

-2

📊

NET INCOME

-16

-34

-66

-84

-128

-132

-105

-101

📊

Net Income Growth (1Y)

-117.04%

-94.54%

-26.47%

-52.79%

-3.37%

+20.51%

+0.31%

+3.41%

📊

Net Income Growth (5Y)

-715.83%

-288.55%

-58.76%

-25.15%

-20.89%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.06

-0.79

-1.54

-1.82

-2.62

-2.67

-1.52

-1.27

-1

📊

Diluted EPS

-1.06

-0.79

-1.54

-1.82

-2.62

-2.67

-1.52

-1.27

-1

📊

Basic Average Shares

112

📊

Diluted Average Shares

112

📊

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	19	21	33	46	31	21	36	36	28	📊
Revenue Growth (1Y)	--	+10.42%	+55.25%	+37.93%	-32.08%	-33.25%	+71.44%	+1.02%	-21.00%	📊
Revenue Growth (5Y)	--	--	--	--	+60.59%	-2.92%	+7.20%	-21.49%	-37.98%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	29	48	77	3	8	8	8	8	2	📊
Cost of Revenue Growth (1Y)	--	+66.70%	+62.53%	-96.25%	+160.47%	+2.18%	+2.03%	+1.03%	-77.42%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-73.52%	-83.77%	-89.81%	+174.34%	-38.05%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	-9	-26	-44	43	24	13	36	28	27	📊
Gross Profit Growth (1Y)	--	-184.82%	-68.45%	+196.85%	-45.14%	-44.66%	+173.32%	-21.39%	-4.92%	📊
Gross Profit Growth (5Y)	--	--	--	--	+354.92%	+149.53%	+180.37%	-34.76%	-37.97%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	36	57	94	125	153	152	155	132	145	📊
Operating Expenses Growth (1Y)	--	+58.96%	+64.77%	+33.50%	+22.43%	-0.66%	+2.07%	-14.65%	+9.47%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+328.10%	+167.54%	+65.73%	+5.96%	+15.99%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	7	9	15	33	43	42	42	36	34	📊
Research and Development	29	48	78	95	118	118	111	104	100	📊
Other Income Expenses	-0	0	0	-3	-8	-8	2	-8	11	📊
EBITDA	-15	-31	-63	-79	-124	-122	-103	-103	-107	📊
EBITDA Growth (1Y)	--	-102.14%	-105.82%	-25.36%	-57.64%	+1.75%	+15.34%	+0.44%	-3.81%	📊
EBITDA Growth (5Y)	--	--	--	--	-722.20%	-299.60%	-64.36%	-30.54%	-35.50%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	4	3	3	3	2	8	2	2	3	📊
Operating Income	-16	-35	-60	-82	-130	-139	-120	-104	-112	📊
Operating Income Growth (1Y)	--	-116.32%	-70.51%	-35.87%	-57.71%	-7.33%	+13.97%	+12.64%	-6.96%	📊
Operating Income Growth (5Y)	--	--	--	--	-690.37%	-292.17%	-97.88%	-27.22%	-36.08%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	1	2	2	1	0	0	--	📊
Pre Tax Income	-16	-33	-67	-84	-128	-131	-105	-105	-101	📊
Tax Provision	0	1	-1	2	-2	1	0	0	--	📊
NET INCOME	-16	-34	-66	-84	-128	-132	-105	-105	-101	📊
Net Income Growth (1Y)	--	-117.04%	-94.54%	-26.47%	-52.79%	-3.37%	+20.51%	+0.31%	+3.41%	📊
Net Income Growth (5Y)	--	--	--	--	-715.83%	-288.55%	-58.76%	-25.15%	-20.89%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.06	-0.79	-1.54	-1.82	-2.62	-2.67	-1.52	-1.27	-1	📊
Diluted EPS	-1.06	-0.79	-1.54	-1.82	-2.62	-2.67	-1.52	-1.27	-1	📊
Basic Average Shares	15	43	43	46	49	50	69	83	112	📊
Diluted Average Shares	42	43	43	46	49	50	69	83	112	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+10.42%

+55.25%

+37.93%

-32.08%

-33.25%

+71.44%

+1.02%

-21.00%

📊

Revenue Growth (5Y)

+60.59%

-2.92%

+7.20%

-21.49%

-37.98%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+66.70%

+62.53%

-96.25%

+160.47%

+2.18%

+2.03%

+1.03%

-77.42%

📊

Cost of Revenue Growth (5Y)

-73.52%

-83.77%

-89.81%

+174.34%

-38.05%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-9

-26

-44

📊

Gross Profit Growth (1Y)

-184.82%

-68.45%

+196.85%

-45.14%

-44.66%

+173.32%

-21.39%

-4.92%

📊

Gross Profit Growth (5Y)

+354.92%

+149.53%

+180.37%

-34.76%

-37.97%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

125

153

152

155

132

145

📊

Operating Expenses Growth (1Y)

+58.96%

+64.77%

+33.50%

+22.43%

-0.66%

+2.07%

-14.65%

+9.47%

📊

Operating Expenses Growth (5Y)

+328.10%

+167.54%

+65.73%

+5.96%

+15.99%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

118

111

104

100

📊

Other Income Expenses

-0

-3

-8

📊

EBITDA

-15

-31

-63

-79

-124

-122

-103

-107

📊

EBITDA Growth (1Y)

-102.14%

-105.82%

-25.36%

-57.64%

+1.75%

+15.34%

+0.44%

-3.81%

📊

EBITDA Growth (5Y)

-722.20%

-299.60%

-64.36%

-30.54%

-35.50%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-16

-35

-60

-82

-130

-139

-120

-104

-112

📊

Operating Income Growth (1Y)

-116.32%

-70.51%

-35.87%

-57.71%

-7.33%

+13.97%

+12.64%

-6.96%

📊

Operating Income Growth (5Y)

-690.37%

-292.17%

-97.88%

-27.22%

-36.08%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-16

-33

-67

-84

-128

-131

-105

-101

📊

Tax Provision

-1

-2

📊

NET INCOME

-16

-34

-66

-84

-128

-132

-105

-101

📊

Net Income Growth (1Y)

-117.04%

-94.54%

-26.47%

-52.79%

-3.37%

+20.51%

+0.31%

+3.41%

📊

Net Income Growth (5Y)

-715.83%

-288.55%

-58.76%

-25.15%

-20.89%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.06

-0.79

-1.54

-1.82

-2.62

-2.67

-1.52

-1.27

-1

📊

Diluted EPS

-1.06

-0.79

-1.54

-1.82

-2.62

-2.67

-1.52

-1.27

-1

📊

Basic Average Shares

112

📊

Diluted Average Shares

112

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	1.03%
Next Earnings
Market cap	443.06M (USD)
EPS (TTM)	-1.00 ($)
P/E (TTM)	-3.39 ($)
Last Close	3.39

Next Earnings
Market cap	443.06M (USD)
EPS (TTM)	-1.00 ($)
P/E (TTM)	-3.39 ($)
Last Close	3.39 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	1.03%
Next Earnings
Market cap	443.06M (USD)
EPS (TTM)	-1.00 ($)
P/E (TTM)	-3.39 ($)
Last Close	3.39

Next Earnings
Market cap	443.06M (USD)
EPS (TTM)	-1.00 ($)
P/E (TTM)	-3.39 ($)
Last Close	3.39 ($)